Comparison of the Success of Pulmonary TB Treatment Before and After the COVID-19 Pandemic
Keywords:
Tuberculosis, COVID-19, Treatment Success RateAbstract
Abstract. Tuberculosis (TB) remains a major global public health challenge and continues to be one of the leading causes of illness and death from infectious diseases. Indonesia is the country with the second-highest TB burden worldwide after India, making TB control an essential national priority. The COVID-19 pandemic disrupted many essential health services, including TB programs, and may have affected treatment outcomes. This study aimed to compare the Treatment Success Rate (TSR) of pulmonary TB patients before and after the COVID-19 pandemic in primary health centers in Bandung City. This analytical observational research used a cross-sectional design with secondary data obtained from the Bandung Open Data Portal for the years 2018–2022. The period 2018–2019 was classified as pre-pandemic, while 2020–2022 represented the post-pandemic period. Data were analyzed using the Mann–Whitney test. Results showed that the average TSR increased from 80.1% before the pandemic to 88.55% after the pandemic; however, the difference was not statistically significant (p > 0.05). The TSR also remains below the WHO target of ≥90%. Strengthening TB services in the post-pandemic period—particularly in adherence monitoring, follow-up sputum examinations, and optimization of primary healthcare—will be essential to improving treatment outcomes.
References
World Health Organization, Global Tuberculosis Report 2023. World Health Organization, 2023.
World Health Organization, “Global Tuberculosis Report 2024,” Nov. 2024.
N. Maria, H. Wilda Risni, and K. Citra Dewi Permata Sari, “Dampak Pandemi COVID-19 Terhadap Keberhasilan Pengobatan Tuberkulosis: Scoping Review,” 2023, doi: 10.20956/mff.SpecialIssue.
I. Mbithi et al., “Assessing the real-time impact of covid-19 on tb and hiv services: The experience and response from selected health facilities in nairobi, kenya,” Trop. Med. Infect. Dis., vol. 6, Jun. 2021, doi: 10.3390/tropicalmed6020074.
I. Rodrigues, A. Aguiar, G. B. Migliori, and R. Duarte, “Impact of the COVID-19 pandemic on tuberculosis services,” Pulmonology, vol. 28, pp. 210–219, May 2022, doi: 10.1016/j.pulmoe.2022.01.015.
Kementrian Kesehatan RI, “Strategi Nasional Penanggulangan Tuberkulosis di Indonesia 2020-2024,” 2020.
WHO, “End TB Strategy: Global Strategy and Targets for Tuberculosis Prevention, Care and Control after 2015,” 2016. [Online]. Available: http://www.who.int/tb
K. Lönnroth and M. Raviglione, “The WHO’s new end tb strategy in the post-2015 era of the sustainable development goals,” Oct. 2015, Oxford University Press. doi: 10.1093/trstmh/trv108.
Hamdin, A. Hamid, and Cahyadin, “Adaptasi Tata Laksana Tuberkulosis Selama Pandemi Covid-19 di Kabupaten Bima,” vol. 7, no. 1, 2023.
N. R. A. Zulfa and N. A. Prihartono, “Karakteristik Pasien Tuberkulosis di Kota Bandung Tahun 2021,” Jurnal Integrasi Kesehatan & Sains, vol. 5, no. 2, pp. 155–158, Jul. 2023, doi: 10.29313/jiks.v5i2.11804.
T. N. Arifah, “Gambaran Kualitas Hidup Pada Pasien Tuberkulosis Paru Di Puskesmas Padasuka Kecamatan Cibeunying Kidul Kota Bandung,” 2015.
Y. Triyani, S. Achmad, R. Retno Ekowati, and B. Patologi Klinik Fakultas Kedokteran Universitas Islam Bandung, “Pendampingan Kader Posyandu pada Pelaksanaan Program Investigasi Kontak Erat Pasien Tuberkulosis Paru di Wilayah Kerja Puskesmas Margahayu Raya Kota Bandung 2 3 1*,” 2024.
WHO, Global Tuberculosis Report 2021. World Health Organization, 2021.
M. Abdulkader, I. Van Aken, S. Niguse, H. Hailekiros, and M. Spigt, “Treatment outcomes and their trend among tuberculosis patients treated at peripheral health settings of Northern Ethiopia between 2009 and 2014: A registry-based retrospective analysis,” BMC Res. Notes, vol. 12, no. 1, Dec. 2019, doi: 10.1186/s13104-019-4824-9.
M. A. Cardoso, P. E. A. A. D. Brasil, C. A. S. Schmaltz, F. M. Sant’Anna, and V. C. Rolla, “Tuberculosis Treatment Outcomes and Factors Associated with Each of Them in a Cohort Followed Up between 2010 and 2014,” Biomed Res. Int., vol. 2017, 2017, doi: 10.1155/2017/3974651.
B. Utomo et al., “DOES COVID-19 PANDEMIC AFFECT THE ELIMINATION OF TUBERCULOSIS? LESSONS LEARNED FROM INDONESIA,” Afr. J. Infect. Dis., vol. 19, no. 2, pp. 1–7, Apr. 2025, doi: 10.21010/AJIDV19I2.1.
H. Surendra et al., “Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: a nationwide longitudinal analysis of programme data,” 2023. [Online]. Available: https://data.
V. Gunsaru, M. Y. R. Henrion, and C. F. McQuaid, “The impact of the COVID-19 pandemic on tuberculosis treatment outcomes in 49 high burden countries,” BMC Medicine 2024 22:1, vol. 22, no. 1, pp. 312-, Jul. 2024, doi: 10.1186/S12916-024-03532-7.
Aini Agnia and Heni Muflihah, “Tingkat Kepatuhan Pengobatan Pasien Fase Intensif Berdasarkan Karakteristik Pasien TB di Puskesmas Rancasalak,” Jurnal Riset Kedokteran, pp. 57–60, Jul. 2022, doi: 10.29313/jrk.vi.890.
Clarisa Alfatihah Erman, Heni Muflihah, and Ismawati, “Studi Literatur: Peran Status Gizi pada Hasil Akhir Pengobatan Tuberkulosis Paru Anak,” Jurnal Riset Kedokteran, vol. 4, no. 1, pp. 51–58, Jul. 2024, doi: 10.29313/jrk.v4i1.4398.
